A 51˶ Clinical Challenges series discussed three areas of cancer immunotherapy: neoadjuvant immunotherapy, cancer vaccines, and immunotherapy for non-small cell lung cancer (NSCLC) with driver mutations.
This three-question quiz will test your knowledge on one aspect of each of the articles in this series. Correct answers and explanations appear after completing the quiz.